h2o Therapeutics will soon be able to call on the marketing reach of pharma distributor AmerisourceBergen for its app for patients with Parkinson’s disease.
Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi it held earlier this year as uptake remains sluggish.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.